A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur

Completed

Conditions studied: Juvenile Idiopathic Arthritis

In brief

This study will determine the incidences of infections and malignancies among JIA patients treated with abatacept

Key facts

Study ID

NCT03769558

Run by

Bristol-Myers Squibb

People needed

264

Starts

2016-07-12

Expected to finish

2016-09-30

Last updated by the study team

2020-03-20

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Two diagnoses of JIA (ICD-9 code 714.3x) within 90 days
• Age less than 18 years at the time of second of the two diagnoses
• Index date is the date of initiating treatment with abatacept

You may not qualify if…

• Greater than or equal to 18 years of age

Where it is running

• Local Institution — Princeton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.